The Assignment
Since its founding in 2008, OmniAb has built best-in-class therapeutic human antibody platforms. OmniAb applies proprietary, AI-powered antigen generation techniques to highly optimized next-generation transgenic animals. They then tap into the unparalleled powers of biological intelligence and in vivo maturation to generate massive numbers of targeted antibodies.
The OmniAb team engaged with CG Life to help create a new company website that levels up their look and feel while telling a cohesive brand story about their best-in-class technology offerings.
Home Page
Technology Page
Transgenic Chickens
Back to Top